2023 World Baseball Classic Begins, Taiwan Excellence Supports
8.3.2023 11:10:00 EET | Business Wire | Press release
The World Baseball Classic (WBC) is returning to Taiwan, after a ten-year hiatus, for the qualifying rounds. The tournament will feature teams from Taiwan, the Netherlands, Cuba, Italy, and Panama, who will showcase their skills starting on March 8th. As the host country for the A-group preliminaries, Taiwan extends a warm welcome to the players through enthusiastic fans, fascinating cuisine, and the opportunity to experience the latest Taiwan Excellence awarded technology and lifestyle products.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230311005004/en/
The WBC was postponed for two years due to the impact of COVID-19. With hygiene and safety being top priorities, Major League Baseball (MLB) has adopted stringent standards for the event. The Taiwanese organizers have prepared the world's first indoor wireless rapid antibacterial machine, the AQUECARE T1 Plus sanitizer. This innovative solution has received the Taiwan Excellence Award and will play a vital role in maintaining environmental hygiene throughout the tournament.
Because long-haul flights can cause fatigue among players, posing them a significant challenge, the organizers have provided the world's first AURAI intelligent eye massager in order to facilitate more rapid recovery. This device helps to alleviate eye fatigue, improves sleep quality, and will recharge energy levels for the players. They will also be able to use AROMASE all-in-one purifying gel which contains three different types of herbal extracts. This gel is effective in purifying the body and mind after each training session and competition. Furthermore, we prioritize environmental sustainability, and have prepared O’right toothpaste, a revolutionary toothpaste made from sustainable tree powder as a grinding agent. This toothpaste is certified by USDA Biobased.
Taiwan is well-known as a technology island, and its consumer electronics and ICT products have gained recognition from consumers worldwide. So, the organizers are providing the players with another Taiwan Excellence awarded product, the PX 4K HDR Wireless Presentation Receiver. This product supports 4K HDR wireless transmission and provides a convenient 4K wireless projection function from mobile phones and laptops to televisions, enabling players to relax and enjoy different forms of entertainment when away from the intensity of competition.
As a souvenir for players from around the world, the Qubii auto-backup device has been chosen. This is a hand-sized device that automatically backs up photos, videos, contacts, and other content while your phone is charging. This device allows players to easily back up precious game data and memories when they run out of phone storage.
Taiwan is making every effort to provide a comfortable and safe environment with the very best professional equipment, in the hopes that the teams will enjoy their stay in Taiwan and maximize their performance in the WBC. Taiwan Excellence, a globally recognized symbol of product quality and innovative design, plays an important role in this commitment. Taiwan Excellence will continue to discover and introduce more high-quality Taiwanese products, featuring innovative breakthroughs to the world, enriching the lives of people everywhere.
For more information, please visit our website https://www.taiwanexcellence.org/en
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230311005004/en/
Contact information
Brain Lee, TAITRA
brianlee@taitra.org.tw
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Fujirebio Expands Access in Canada to Blood-based Neurology Testing with Health Canada Class II Medical Device Licenses for the Lumipulse® G NfL Blood and Lumipulse G pTau 217 Plasma Assays1.9.2026 08:00:00 EEST | Press release
H.U. Group Holdings Inc. and its wholly owned subsidiary Fujirebio today announced that Health Canada has issued Class II Medical Device Licenses (MDL) for the Lumipulse G NfL Blood and the Lumipulse G pTau 217 Plasma assay for use on the fully automated LUMIPULSE® G immunoassay platform in the Canadian market. "The approval of the Lumipulse G NfL Blood and Lumipulse G pTau 217 Plasma assays for clinical use in Canada marks another important step in our mission to expand access to reliable and clinically meaningful blood-based biomarkers for clinicians and patients worldwide," said Christiaan De Wilde, CEO of Fujirebio Europe N.V. “As a pioneer in neurological diagnostics, Fujirebio remains committed to advancing patient care through innovative, fully automated testing solutions." These approvals further strengthen Fujirebio’s comprehensive neurological diagnostics portfolio by broadening access to high-quality biomarker solutions designed to inform clinical decision-making across the
Helical Fusion Named a Final Candidate for Japan’s METI Fusion Power Demonstration Program1.9.2026 05:00:00 EEST | Press release
Helical Fusion Co., Ltd., a fusion energy company developing a Helical Stellarator toward commercially viable fusion power, has been named a final candidate for Japan’s Ministry of Economy, Trade and Industry (METI) program supporting the demonstration of fusion power generation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260831991676/en/ Image of Helix HARUKA, Helical Fusion’s Integrated Demo Device(left), and Helix KANATA, Helical Fusion’s Fusion Pilot Plant(right) The program is designed to accelerate fusion power demonstration in the 2030s under Japan’s national energy and fusion strategies. It supports private-sector technology development across multiple fusion approaches, including tokamak, stellarator and laser fusion, with approximately JPY 60 billion in total government support anticipated over the three years through 2028. The amount to be awarded to Helical Fusion will be announced following the formal grant
Strategic Combination of ITC Infotech and Happiest Minds Technologies to Create a Scaled, Future-Ready, AI-First Global Technology Services Enterprise with US$ 1 Billion Revenue by FY28 [1]1.9.2026 00:35:00 EEST | Press release
ITC Infotech (ITCI), a wholly owned subsidiary of ITC Limited and a leading global technology services player, today announced the proposed strategic combination with Happiest Minds Technologies Limited (Happiest Minds) to create a scaled, future-ready, AI-first global technology services enterprise. The ITCI Board approved a proposal to acquire 22.1% equity stake from the promoter of Happiest Minds in two tranches under a Share Purchase Agreement. The transaction would be funded through a Rights Issue by ITC Infotech. ITCI Board has also approved a proposed Scheme of Amalgamation of Happiest Minds with ITCI which will be effected after the share acquisition. Pursuant to the scheme, the shares of ITCI will be listed on the stock exchanges. The proposed transaction has also been endorsed by the Board of Directors of ITC Limited. This strategic combination will synergistically blend ITCI’s AI-led capabilities across Cloud, Data Analytics, PLM, SAP, enterprise transformation, industry-spe
Angel’s Profits Grew Robustly in the First Half of 2026 with Europe and North America Turning Profitable Ahead of Schedule31.8.2026 22:07:00 EEST | Press release
Angelalign Technology Inc. (“Angel” or the “Company”) (6699.HK) (angelaligner.com), the second largest clear aligner supplier by revenue, announced today that its revenue grew 42.9% to US$230.7 million and net profit grew 79.6% to $25.5 million for the six months ending June 30, 2026. Angel’s business in Europe and North America crossed into profitability ahead of plan while the business in Chinese mainland delivered market share gains well above expectations. Doctors and staff in every region report that they are increasingly selecting Angel’s solutions after experiencing more predictable outcomes, especially on complex cases, and embracing the positive culture of the company. Dr. Mark Holt D.D.S., M.S. of Holt Orthodontics in Northern California, states: “We treat over half of our patients with clear aligners and our experience with Angel’s treatment plans and clear aligners has been tremendous.” “Our main focus is to provide great service to and being a rock-solid partner for our cu
BeOne Medicines Announces Voluntary Agreement with U.S. Government to Expand Access to Innovative Cancer Medicines31.8.2026 22:00:00 EEST | Press release
BeOne Medicines, Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced a voluntary agreement with the U.S. Government to expand access to innovative cancer medicines for American patients while strengthening our U.S manufacturing footprint and further expanding the capabilities needed to deliver medicines at scale. The agreement builds on BeOne's longstanding commitment to patient access and investment in research and scientific innovation. John V. Oyler, Co-Founder, Chairman and CEO, BeOne Medicines, said: “At BeOne, we believe every patient should benefit from innovative cancer therapies. We appreciate the Trump Administration’s commitment to advancing solutions that broaden access and scientific progress for American patients. This agreement reflects our purpose to reach more patients as we expand our U.S. investment in additional research, development, and manufacturing to deliver breakthrough cancer treatments worldwide.” Improved access to oncol
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
